IL23R and IL12B polymorphisms in spanish IBD patients: No evidence of interaction
Authors:
- Ana MárquezAMAna Márquez
- Juan Luis MendozaJMJuan Luis Mendoza
- Carlos TaxoneraCTCarlos Taxonera
- Manuel Díaz-RubioMDManuel Díaz-Rubio
- Emilio G. De La ConchaECEmilio G. De La Concha
- Elena UrcelayEUElena Urcelay
- Alfonso MartínezAMAlfonso Martínez
- 1 September 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 14 (9) , 1192-1196
Abstract
Recent genomic surveys have identified IL23R and IL12B as susceptibility loci for inflammatory bowel disease (IBD). Our aim in the present study was to ascertain whether the IL23R and IL12B associations with IBD are also observed in our population, and to analyze possible genetic interactions between polymorphisms at IL12B and IL23R, ligand and receptor, respectively. In all, 707 IBD patients (344 with Crohn's disease and 363 with ulcerative colitis) and 547 healthy controls from the same ethnic origin (Caucasian Spaniards) were included in the present study. Two single nucleotide polymorphisms (SNPs) in IL23R (rs7517847 and rs11209026) and 2 in IL12B (rs3212227 and rs6887695) genes were analyzed by TaqMan technology. Genetic frequencies were compared with a chi-square test. Interaction between genes was analyzed by case-only comparisons. The data show an association of both IL23R SNPs with overall IBD (statistically stronger, rs7517847; odds ratio [OR] = 0.79, 95% confidence interval [CI]: 0.67-0.94, minor allele frequencies: 0.355 in IBD patients versus 0.410 in controls; P = 0.005), somewhat stronger in Crohn's disease (OR = 0.74, 95% CI: 0.61-0.91) than in ulcerative colitis (OR = 0.84, 95% CI: 0.69-1.03). IL12B rs6887695 showed a weak association with IBD (OR = 1.24, 95% CI: 1.04-1.47, minor allele frequencies: 0.375 in IBD patients versus 0.326 in controls, P = 0.012), stronger in UC (OR = 1.31, 95% CI: 1.07-1.60, P = 0.007). No statistically significant differences were apparent when patients were stratified according to clinical characteristics. No interaction was observed between any of the polymorphisms studied at IL12B and IL23R. Our study confirms the association of IL23R and IL12B with IBD in the Spanish population, but no interaction between either loci could be detected.Keywords
This publication has 35 references indexed in Scilit:
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsNature Genetics, 2007
- Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease lociProceedings of the National Academy of Sciences, 2007
- STAT4and the Risk of Rheumatoid Arthritis and Systemic Lupus ErythematosusNew England Journal of Medicine, 2007
- Development, cytokine profile and function of human interleukin 17–producing helper T cellsNature Immunology, 2007
- Phenotypic and functional features of human Th17 cellsJournal of Experimental Medicine, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibilityNature Genetics, 2007
- IL-23 receptor (IL-23R) gene protects against pediatric Crohnʼs diseaseInflammatory Bowel Diseases, 2007
- IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel DiseaseGastroenterology, 2007
- Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesisNature Genetics, 2007